Published in Am J Med on February 01, 1985
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother (1990) 4.17
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev (1992) 1.84
Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A (2015) 1.76
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.70
Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev (2004) 1.60
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg Infect Dis (2003) 1.49
Clinical implications of positive blood cultures. Clin Microbiol Rev (1989) 1.48
Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. Antimicrob Agents Chemother (1987) 1.33
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother (1996) 1.29
Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin. Antimicrob Agents Chemother (1987) 1.23
Teicoplanin in the treatment of gram-positive-bacterial endocarditis. Antimicrob Agents Chemother (1989) 1.19
Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev (2010) 1.12
Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin Proc (2012) 1.00
Serum C reactive protein in infective endocarditis. J Clin Pathol (1988) 0.97
Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Antimicrob Agents Chemother (1995) 0.96
The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis. Postgrad Med J (1987) 0.92
Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci. Antimicrob Agents Chemother (1996) 0.88
Pathogenicity of the enterococcus in surgical infections. Ann Surg (1990) 0.88
Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases. Case Rep Med (2011) 0.88
Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously. Antimicrob Agents Chemother (1994) 0.87
Serum bactericidal test. Clin Microbiol Rev (1988) 0.86
An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. Virulence (2013) 0.86
Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers. Antimicrob Agents Chemother (1987) 0.86
Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers. Antimicrob Agents Chemother (1991) 0.84
Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly. Antimicrob Agents Chemother (1990) 0.83
Influence of technical factor variations on serum inhibition and bactericidal titers. J Clin Microbiol (1986) 0.81
Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr Infect Dis Rep (2015) 0.81
Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. Antimicrob Agents Chemother (1989) 0.80
The role of the infectious diseases physician in setting guidelines for antimicrobial use. Bull N Y Acad Med (1987) 0.78
Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers. Antimicrob Agents Chemother (1993) 0.75
4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin. Antimicrob Agents Chemother (1992) 0.75
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Meningococcal disease. N Engl J Med (2001) 8.50
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49
Campylobacter enteritis. N Engl J Med (1981) 7.98
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19
A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med (1993) 6.18
Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A (1997) 5.90
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol (1992) 5.09
Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet (1999) 4.64
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis (1983) 4.52
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol (1990) 4.35
Update on detection of bacteremia and fungemia. Clin Microbiol Rev (1997) 4.01
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Vertebrate pseudogenes. FEBS Lett (2000) 3.93
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol (1995) 3.51
Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85
Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis (1998) 2.81
Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens. J Clin Microbiol (1981) 2.77
Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis (1999) 2.57
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54
Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol (1993) 2.49
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1987) 2.39
Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother (1987) 2.35
Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis (1973) 2.35
Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med (1992) 2.33
Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol (1994) 2.32
Comparison of acridine orange, methylene blue, and Gram stains for blood cultures. J Clin Microbiol (1982) 2.30
A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis (2000) 2.29
Simplified assay for gentamicin in the presence of other antibiotics. Antimicrob Agents Chemother (1973) 2.26
Effect of agitation and terminal subcultures on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system. J Clin Microbiol (1989) 2.25
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J Antimicrob Chemother (1982) 2.25
Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol (2001) 2.23
Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. J Clin Microbiol (1995) 2.21
Clinical microbiology in developing countries. Emerg Infect Dis (2001) 2.18
Clinical impact of bacteria and fungi recovered only from broth cultures. J Clin Microbiol (1995) 2.17
Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30-day) results. J Vasc Surg (1996) 2.14
Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med (1981) 2.07
Diagnostic utility of postmortem blood cultures. Arch Pathol Lab Med (1993) 2.06
Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol (1990) 2.06
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Application of rejection criteria for stool ovum and parasite examinations. J Clin Microbiol (1992) 2.04
Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04
Evaluation of preservative fluid for urine collected for culture. J Clin Microbiol (1979) 2.03
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis. J Clin Microbiol (1985) 1.97
Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol (1994) 1.97
Pilus- and non-pilus-mediated interactions of Haemophilus influenzae type b with human erythrocytes and human nasopharyngeal mucosa. J Infect Dis (1990) 1.97
Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria. J Clin Microbiol (1993) 1.94
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol (1993) 1.91
Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells. J Infect Dis (1983) 1.86
Attachment of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell. J Infect Dis (1981) 1.84
Characterization of the gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis. J Bacteriol (1998) 1.83
A unifying explanation of primary generalized seizures through nonlinear brain modeling and bifurcation analysis. Cereb Cortex (2005) 1.83
Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis (1993) 1.83
Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit Rev Microbiol (1998) 1.82
Controlled comparison of original vented aerobic fan medium with new nonvented BacT/ALERT FA medium for culturing blood. J Clin Microbiol (2001) 1.81
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth. J Clin Microbiol (1982) 1.81
Alu sequences. FEBS Lett (1997) 1.81
Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80
Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J Infect Dis (2001) 1.79
Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med (1983) 1.79
The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun (1998) 1.78